Table 7.
Model-based estimates of cure fraction (CF, %) (centered at 2010 as the year of diagnosis), net survival (NS, %) 50 years after diagnosis, until 100 years of age, and until 90 years of age, for selected cancer types by sex and age at diagnosis.
| Cancer type (sex) | CF | NS until | ||
|---|---|---|---|---|
| Age at diagnosis (years) | 50 years after the diagnosis | Age 100 years | Age 90 years | |
| All cancers (men) | ||||
| 0–14 | 76% | 79% | 79% | 79% |
| 15–44 | 72% | 77% | 77% | 77% |
| 45–54 | 51% | 56% | 56% | 57% |
| 55–64 | 46% | 53% | 53% | 53% |
| 65–74 | 41% | 48% | 49% | 50% |
| 75+ | 35% | 37% | 38% | 41% |
| All cancers (women) | ||||
| 0–14 | 79% | 81% | 81% | 81% |
| 15–44 | 75% | 79% | 79% | 79% |
| 45–54 | 68% | 72% | 72% | 72% |
| 55–64 | 55% | 60% | 61% | 62% |
| 65–74 | 44% | 48% | 50% | 52% |
| 75+ | 34% | 36% | 36% | 39% |
| Breast (women) | ||||
| 0–44 | 72% | 77% | 77% | 77% |
| 45–54 | 77% | 82% | 82% | 82% |
| 55–64 | 71% | 77% | 77% | 78% |
| 65–74 | 61% | 69% | 72% | 76% |
| 75+ | 47% | 51% | 60% | 72% |
| Prostate (men) | ||||
| 0–44 | 68% | 78% | 78% | 78% |
| 45–54 | 86% | 93% | 93% | 93% |
| 55–64 | 89% | 95% | 95% | 95% |
| 65–74 | 81% | 91% | 93% | 94% |
| 75+ | 59% | 68% | 73% | 80% |